The first of which is that of the phase 3 ENHANCE study targeting a consolidated infusion schedule of BRIUMVI. The second of which involves a self-administered at-home subcutaneous treatment of ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results